Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Sheikh Mohammad Fazle Akbar, Mamun Al-Mahtab, Munira Jahan, Osamu Yoshida & Yoichi Hiasa. (2016) Novel insights into immunotherapy for hepatitis B patients. Expert Review of Gastroenterology & Hepatology 10:2, pages 267-276.
Read now
Read now
En-Qiang Chen, Ying Shi, Dong-Bo Wu & Hong Tang. (2014) Liquid oral suspension adefovir dipivoxil (GS-02-526): an update on treatments for hepatitis B infection. Expert Review of Anti-infective Therapy 12:8, pages 919-928.
Read now
Read now
Sheikh Mohammad Fazle Akbar, Mamun Al-Mahtab & Md. Sakirul Islam Khan. (2013) Non-antigen-specific and antigen-specific immune therapies for chronic hepatitis B: evidences from laboratory benches and patient's bedsides. Expert Opinion on Biological Therapy 13:7, pages 1063-1074.
Read now
Read now
Steven-Huy Han, Wuhua Jing, Edward Mena, Michael Li, Brett Pinsky, Hong Tang, Tony Hebden & Timothy Juday. (2012) Adherence, persistence, healthcare utilization, and cost benefits of guideline-recommended hepatitis B pharmacotherapy. Journal of Medical Economics 15:6, pages 1159-1166.
Read now
Read now
Articles from other publishers (17)
Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Julio Cesar Aguilar, Md. Helal Uddin, Md. Sakirul Islam Khan, Osamu Yoshida, Eduardo Penton, Guillen Nieto Gerardo & Yoichi Hiasa. (2021) Exploring evidence-based innovative therapy for the treatment of chronic HBV infection: experimental and clinical. Exploration of Medicine.
Crossref
Crossref
SharkerM. S. Hossain, MamunA Mahtab, DulalC Das, SheikhM Noor-E-Alam, AyubA Mamun, Md. SakirulI Khan, SheikhM. F. Akbar, MdZakiur Rahman & Salimur Rahman. (2021) Comparative role of tenofovir versus entecavir for treating patients with hepatitis B virus-related acute on chronic liver failure. Journal of Family Medicine and Primary Care 10:7, pages 2642.
Crossref
Crossref
Junjie Song, Xiangling Yu, Wenlong Song, Dajing Guo, Chuanming Li, Huan Liu, Haiping Zhang, Jun Zhou & Yangyang Liu. (2020)
MRI
‐Based Radiomics Models Developed With Features of the Whole Liver and Right Liver Lobe: Assessment of Hepatic Inflammatory Activity in Chronic Hepatic Disease
. Journal of Magnetic Resonance Imaging 52:6, pages 1668-1678.
Crossref
Crossref
Kiyoaki Ito, Masashi Yoneda, Kazumasa Sakamoto & Masashi Mizokami. (2017) Virological and Clinical Characteristics of Hepatitis B Virus Genotype A. Journal of Gastroenterology 53:1, pages 18-26.
Crossref
Crossref
Nai-Hsuan Chien, Yen-Tsung Huang, Chun-Ying Wu, Chi-Yang Chang, Ming-Shiang Wu, Jia-Horng Kao, Lein-Ray Mo, Chi-Ming Tai, Chih-Wen Lin, Tzeng-Huey Yang, Jaw-Town Lin & Yao-Chun Hsu. (2017) Time-varying serum gradient of hepatitis B surface antigen predicts risk of relapses after off-NA therapy. BMC Gastroenterology 17:1.
Crossref
Crossref
Yolanda Borrego Izquierdo, Encarnación Gómez Fernández, Patricia Monje Agudo, Rocío Jiménez Galán, Carmen V Almeida-González, Mónica Ferrit Martín & Ramón Morillo Verdugo. (2016) Persistence profile to nucleos(t)ide analogue treatment for patients with chronic hepatitis B. European Journal of Hospital Pharmacy 23:5, pages 278-282.
Crossref
Crossref
En-Qiang Chen, Jie Dai, Lang Bai & Hong Tang. (2015) The efficacy of zinc finger antiviral protein against hepatitis B virus transcription and replication in tansgenic mouse model. Virology Journal 12:1.
Crossref
Crossref
Jia-Horng Kao. (2015) Hepatitis B vaccination and prevention of hepatocellular carcinoma. Best Practice & Research Clinical Gastroenterology 29:6, pages 907-917.
Crossref
Crossref
Lindsay Govan, Olivia Wu, Yiqiao Xin, Sharon J. Hutchinson & Neil Hawkins. (2015) Comparative effectiveness of antiviral treatment for hepatitis B. European Journal of Gastroenterology & Hepatology 27:8, pages 882-894.
Crossref
Crossref
T.-C. Tseng & J.-H. Kao. (2015) Treating Immune-tolerant Hepatitis B. Journal of Viral Hepatitis 22:2, pages 77-84.
Crossref
Crossref
Yongzhong Wang, Bo-Yu Xue, Longgen Liu, Zhen Zhu, Xin Xu, Hongyu Zhang, Xiangke Pu & Xiaoqin Liu. (2022) Poly-linker primer system for detection of single nucleotide polymorphisms and its application in genotyping hepatitis B virus. Acta Biochimica et Biophysica Sinica 47:2, pages 139-141.
Crossref
Crossref
Sheikh Mohammad Fazle Akbar, Mamun Al-Mahtab & Yoichi Hiasa. (2014) Designing Immune Therapy for Chronic Hepatitis B. Journal of Clinical and Experimental Hepatology 4:3, pages 241-246.
Crossref
Crossref
Jia-Horng Kao. (2014) HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon?. Liver International 34, pages 112-119.
Crossref
Crossref
Rong-Nan Chien, Cheng-Yuan Peng, Jia-Horng Kao, Tsung-Hui Hu, Chun-Che Lin, Chi-Tan Hu, Chi-Yi Chen, Tsai-Yuan Hsieh, Han-Chieh Lin & Wan-Long Chuang. (2014) Higher adherence with 3-year entecavir treatment than lamivudine or telbivudine in treatment-naïve Taiwanese patients with chronic hepatitis B. Journal of Gastroenterology and Hepatology 29:1, pages 185-192.
Crossref
Crossref
Mamun Al-Mahtab, Sheikh Mohammad Fazle Akbar, Julio Cesar Aguilar, Md. Helal Uddin, Md. Sakirul Islam Khan & Salimur Rahman. (2013) Therapeutic potential of a combined hepatitis B virus surface and core antigen vaccine in patients with chronic hepatitis B. Hepatology International 7:4, pages 981-989.
Crossref
Crossref
Sheikh Mohammad Fazle Akbar, Mamun Al-Mahtab, Mohammad Helal Uddin & Md. Sakirul Islam Khan. (2013) HBsAg, HBcAg, and combined HBsAg/HBcAg-based therapeutic vaccines in treating chronic hepatitis B virus infection. Hepatobiliary & Pancreatic Diseases International 12:4, pages 363-369.
Crossref
Crossref
Tai-Chung Tseng & Jia-Horng Kao. (2012) Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog. Journal of Gastroenterology 48:1, pages 13-21.
Crossref
Crossref